Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02464410 · ClinicalTrials.gov registry record · NA
Primary Care Intervention to Reduce Prescription Opioid Overdoses
A NA study of Pain and Drug Overdose, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 299
- Enrollment target
- 1
- Study location
NCT02464410: Completed NA study of Pain and Drug Overdose, sponsored by VA Office of Research and Development.
NCT02464410 is a NA study of Pain and Drug Overdose that has completed, run by VA Office of Research and Development. The registered enrollment target is 299 participants, roughly in line with the 303-participant average among 374 other Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02464410, a NA study of Pain and Drug Overdose, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 299 participants
- Enrollment target
- 1
- Study location
Study Summary
The high rate of adverse events, including overdose, resulting from opioid pain medication use threatens the quality and safety of pain care in the Veterans Health Administration (VHA) and elsewhere and is a critical public health problem in the United States. Pain is a highly common condition among VHA patients, and opioid therapy constitutes a primary mode of pain treatment. This study seeks to address this issue by conducting a randomized controlled trial of a brief conversation to improve opioid safety among Veteran patients receiving long-term opioid therapy. Veterans receiving opioid therapy for pain in primary care will be recruited and randomized to receive either a single session motivational intervention focused on safe opioid use or an equal attention control condition. The primary hypothesis is that the motivational intervention will improve opioid safety, decrease risk behaviors, aberrant opioid use, and total quantities of opioids prescribed relative to the control condition. Study findings will inform efforts to ensure the safety and well-being of Veteran patients with pain.
Primary Outcome
This scale is a total sum of 9 items assessing participant's self-report of engaging in behavior that increases risk for overdose. Higher scores indicate greater risk for overdose. The range for this measure is 0 to 9 in one assessment.
Conditions Studied
Interventions
- BEHAVIORAL Motivational intervention
- BEHAVIORAL Psycho-educational control
- OTHER Long-term opioid therapy informed consent
Study Locations (1)
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2016-08-04 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT02464410 record still lists
NCT02464410 is an interventional study that assigns participants to a tested intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 303-participant average among 374 other Pain trials with a reported enrollment target.
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Motivational intervention is the first listed.
NCT02464410 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02464410 about?
NCT02464410 is a clinical study titled "Primary Care Intervention to Reduce Prescription Opioid Overdoses". The high rate of adverse events, including overdose, resulting from opioid pain medication use threatens the quality and safety of pain care in the Veterans Health Administration (VHA) and elsewhere and is a critical public health problem in the United States. Pain is a highly common condition among...
What is the current status of trial NCT02464410?
This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2016-08-04. Estimated completion is 2021-03-31.
What conditions does trial NCT02464410 study?
This clinical trial studies the following conditions: Pain, Drug Overdose, Opioid Use Disorders.
What interventions are being tested in trial NCT02464410?
The interventions under investigation include: Motivational intervention (BEHAVIORAL), Psycho-educational control (BEHAVIORAL), Long-term opioid therapy informed consent (OTHER).
Who is sponsoring clinical trial NCT02464410?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02464410 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02464410's enrollment target sits among peer trials
299 61st of 374 higher than 312 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI